Reports of recovery from disease due to MGN-3
|
Chronic hepatitis,Chronic Hepatitis, Type B, and Liver Cancer（1）（2）,Chronic C type virus hepatitis（1）（2）（3）,Chronic C type virus hepatitis,stomach cancer,Cirrhosis,,Chronic hepatitis C, liver cancer（1）（2）,Chronic Hepatitis, Type C
Diabetes（1）,（2）,Diabetes (NIDDM),Diabetes (NIDDM), asthma
Breast Cancer（1）（2）（3）（4）（5）（6）（7）（8）（9）,Breast cancer (metastasis in the left neck lymph node) ,Breast cancer and metastases in the brain and lung
Hepatitis C（1）（2）｜Hepatitis C→liver cancer
Prostate cancer（1）（2）（3）（4）｜Colon Cancer（1）（2）（3）（4）,Colonic Cancer/Liver Metastasis,Colon polyp｜Pulmonary adenocarcinoma（1）（2）｜Atopic dermatitis（1）（2）（3）｜Articular rheumatism（1）（2）（3）
｜Endometriosis｜ Bladder cancer,Bladder Carcinoma｜Primary Malignant Lymphoma of the Left Breast ｜Articular Rheumatism｜Lung Cancer/Lib Metastasis,Lung cancer (terminal)｜Stomach Cancer,Stomach cancer (scirrhous)｜Liver cancer｜Metastatic Lung Cancer｜Pancreas Cancer, Gallbladder and Liver Metastasis｜Ovarian tumor｜Malignant liver cancer,Malignant lymphoma｜Infantile asthma｜Tonsillitis｜Pharynx cancer｜Oropharynx cancer｜Rectum cancer, bile duct cancer｜Pulmonary adenocarcinoma→metast asis to the pleura
|
|
|
|
| No. 30 Malignant liver cancer Facility/T Hospital
|
|
Patient's name/K. H AGE/47 years SEX/Male AREA/Shizuoka Prefecture
|
|
History of past diseases and treatments
In February 1999, ultrasonography revealed a liver tumor at a medical examination and the patient
immediately visited the National Cancer Center. As a result of liver biopsy, the patient was diagnosed
with carcinoid. In March, he was admitted to Hokkaido University Hospital. Examination confirmed
a 5-cm tumor and multiple 1-2 cm tumors. The patient was immediately treated with liver
embolotherapy. As a result, the 5-cm tumor was excised but other smaller tumors were not. He was
told he had only half a year to live if the disease was left untreated. The disease did not respond to
treatment with anticancer drugs and the patient was recommended liver transplantation as the last
resort. Reexamination was performed in May to identify the primary lesion and revealed a 2-cm
suspected primary tumor in the rectum. The patient underwent an operation to excise the rectal
tumor. At the time, metastases in other organs than the liver were confirmed so liver transplantation
was judged inapplicable. In July, another operation was performed on metastatic lesions but the
patient was subsequently judged untreatable. He left the hospital in August and visited this hospital
seeking dietary treatment. He was put on a semi-fasting therapy, which is adopted at this hospital as a
basic treatment for cancer, to improve intestinal conditions and treated with a special diet. He was
given immunopotentiators such as MGN-3 4 g daily, dietary fiber foods and plant enzymatic foods
and also underwent treatment with far infrared radiation.
Changes caused by ingestion of MGN-3
As indicated by CT and MRI, the liver cancer did not increase in size over the period from August
1999 to February 2000 but has been shrinking. He has been feeling well in his daily and
professional life.
Evaluation of MGN-3
The patient had been judged untreatable because of extensive metastases in organs other than the
liver and rectum. Half a year of treatment with a strict diet and an immunopotentiator MGN-3
seems to have helped suppress cancer growth and even reverse it.
|
|
| No. 31 Malignant lymphoma Facility/T Hospital
|
|
Patient's name/C. H AGE/64 years SEX/Female AREA/Shizuoka Prefecture
|
|
History of past diseases and treatments
In 1992, the patient was diagnosed with malignant tumor and had her left breast resected. Five years
later, she underwent reoperation because another cancer lesion was detected in the suture on the left
breast. After that, she was treated with chemotherapy with anti-cancer drugs. After 4 months of
hospitalization, the symptoms did not improve and the WBC (white blood cell) count continued to
drop. In August 1999, a new cancer lesion appeared in the right breast. She underwent an operation
and radiotherapy. After radiotherapy, she treated with chemotherapy with anti-cancer drugs until
January 2000, when treatment with anti-cancer drugs was discontinued because the WBC count
decreased to 600. On January 15, 2000, the patient visited this hospital. She still had cancer. She was
put on a special diet that started with semi-fasting and given MGN-3 4 g daily and enzymatic foods
to enhance immunity.
Changes caused by ingestion of MGN-3
A total of 9 tests including CT and ultrasonography were performed in April and confirmed the
disappearance of all lesions. Her complexion and general condition (fatigue-proneness, stiff in the
neck, back pain and pain in the ridge) improved. She is feeling well as of April 15.
Evaluation of MGN-3
The WBC count was too low to perform chemotherapy after 7 years of recurrence and treatment
since the initial discovery of malignant tumor. Malignancies disappeared after 3 months of treatment
at this hospital. A special diet of this hospital and treatment with an immunopotentiator MGN-3 seem
to have improved symptoms.
|
|
|
Patient's name/Y. Y AGE/9 years SEX/Female AREA/Gifu Prefecture
|
|
History of past diseases and treatments
The patient was diagnosed with chronic hepatitis C at the age of 7. She had received no special
treatment and avoided excess exercise. She had waited for sero-conversion to occur as a result of
self-healing but experienced loss of appetite and fatigue-proneness and visited this pharmacy for
consultation.
She took MGN-3 1 g daily and a mixed tea with several herbs.
The serum transaminase activity decreased in a short period and is now within normal limits.
Changes caused by ingestion of MGN-3
A weak flare was observed 1 day after start of ingestion but disappeared after 2 days. There was
an increase in appetite and action.
Evaluation of MGN-3
Because the patient had chronic type hepatitis C and was at the age when immunopotency was
developing, no special treatment was performed with the hope that she would gain
sero-conversion ability as she grew. But she did not improve.
Ingestion of MGN-3 improved immunopotency and hepatitis-associated symptoms.
|
|
|
Patient's name/H. K AGE/4 years SEX/Female AREA/Shizuoka Prefecture
|
|
History of past diseases and treatments
The patient has severe atopic symptoms including reddened swollen face and itching and had
difficulty sleeping. After ingestion of MGN-3 1 g daily and herb-mixed tea, the patient began to
improve the next day. After 1 month, the patient recovered almost normal skin and was relieved
from the itch.
Evaluation of MGN-3
Treatment had immediate effect because the production of inflammatory cytokines and IgE
antibodies was suppressed by the immunomodulating action of MGN-3.
|
|
|
Patient's name/H. K AGE/8 years SEX/Female AREA/Kanagawa Prefecture
|
|
History of past diseases and treatments
The patient developed symptoms of atopic dermatitis at the age of 3. She visited the
dermatologic department and underwent steroid therapy. The patient developed weeping eczema
and suffered pain and itching. The patient began to take MGN-3 1 g daily and herb-mixed tea at
the beginning of September 1999. Atopic symptoms began to improve after 1 week and almost
disappeared after 1 month.
Evaluation of MGN-3
Treatment had immediate effect because the production of inflammatory cytokines and IgE
antibodies was suppressed by the immunomodulating action of MGN-3.
|
|
|
Patient's name/C.A AGE/27 years SEX/Female AREA/Kanagawa Prefecture
|
|
History of past diseases and treatments
A breast-fed 4-month old male infant developed atopic symptoms on his skin. His mother was
given MGN-3 3 g daily and herb-mixed tea. Atopic symptoms began to improve after 3 days and
almost disappeared from his skin after 1 week.
Evaluation of MGN-3
Treatment had immediate effect because the production of inflammatory cytokines and IgE
antibodies was suppressed by the immunomodulating action of MGN-3.
|
|
|
Patient's name/T. H AGE/11 years SEX/Male AREA/Chiba Prefecture
|
|
History of past diseases and treatments
The patient developed asthma at the age of 5 and asthma symptoms always accompanied the
occurrence of a cold. He always shows symptoms of rhinitis and is now taking Theo-Dur and
Azeptin. He began taking MGN-3 3 g daily and mixed tea with several herbs at the beginning of
November 1999. He caught cold in early December and January without attacks of asthma. He
has caught cold less frequently since then and developed no symptoms of asthma these 15
months.
Changes caused by ingestion of MGN-3
His appetite and complexion improved 7 days after start of ingestion of MGN-3. Rhinitis also
improved and sores under his nose disappeared.
Evaluation of MGN-3
He was allergic and predisposed to inflammations. His constitution may have improved as a
result of suppressed production of inflammatory cytokines by the immunomodulator MGN-3.
|
|
|
Patient's name/S. K AGE/9 years SEX/Female AREA/Saitama Prefecture
|
|
History of past diseases and treatments
The patient regularly developed symptoms of tonsillitis and suffered a fever about 40?C. She
began to take MGN-3 0.5 g 4 times daily and herb-mixed tea. After 1 month, regular attacks of
fever disappeared.
Changes caused by ingestion of MGN-3
Two days after start of ingestion of MGN-3, her appetite and constipation began to improve. She
also became able to sleep soundly.
Evaluation of MGN-3
She had too potent granulocytes and too high immunoresponsiveness, which made her
predisposed to inflammations. Her constitution may have improved by the benefit of the
immunomodulator MGN-3.
|
|
| No. 38 Pharynx cancer Facility/N Hospital
|
|
Patient's name/H. T AGE/65 years SEX/Male AREA/Hyogo Prefecture
|
|
History of past diseases and treatments
In the middle of July, 1997, the patient noticed an abnormality in the throat. In October, he even
had difficulty swallowing food and visited N Hospital for examination. He was diagnosed with
oropharynx cancer and told that he had only 1 year to live unless he was operated on. He was also
told that he would lose speech ability because part of the vocal cord and tongue had to be resected
in the operation. Preoperative chemotherapy was tried upon his strong request. Besides
chemotherapeutics, he took MGN-3 6 g daily. In a rotation of 1 week of chemotherapy and 3
recovery weeks, 2 courses of chemotherapy were performed. Although there were some adverse
effects such as reduced appetite and hair loss, recovery of the white blood cell count was
remarkable and the tumor shrank. As a result, N Hospital changed treatment regimen and decided
to switch from surgery to radiotherapy. The patient was irradiated for 10 days and after 10 days, for
an additional 7 days. During the course, the patient received MGN-3 6 g daily. As a result of
treatment with radiotherapy, the tumor almost disappeared and no abnormality was observed on
MRI or CT.
Changes caused by ingestion of MGN-3
Adverse effects on the patient of treatment with anticancer drugs and radiotherapy were clearly
milder compared with other patients in the same room. Treatment was painful but was narrowly
tolerated.
Evaluation of MGN-3
The immunopotentiator MGN-3 reduced damage to the body caused by anticancer drugs and
radiotherapy and increased effectiveness. Consequently, he narrowly avoided surgery and speech
loss.
|
|
| No. 39 Colon cancer Facility/T Hospital
|
|
Patient's name/Y. Y AGE/54 years SEX/Male AREA/Shizuoka Prefecture
|
|
History of past diseases and treatments
In June 1997, he was positive in the occult blood reaction test of the stool in a health checkup. A
complete medical workup revealed colon cancer. He refused the surgical operation his attending
physician recommended and visited this hospital. He underwent treatment of a restricted diet,
acupuncture and qigong and was given MGN-3 3 g daily. There was no increase in tumor marker
points in monthly examinations for 10 months. Endoscopy showed a remarkably decreased tumor
and no metastasis.
Changes caused by ingestion of MGN-3
About 10 months after start of ingestion of MGN-3, the body weight stopped decreasing and
complexion and nutritional conditions improved.
Evaluation of MGN-3
The patient had considerably advanced colon cancer and was recommended immediate surgery. He
chose a treatment that would improve self-healing potential in consideration of QOL. The
treatment resulted in the tumor shrinking and made excision using an endoscope possible. No
metastasis was observed. The immunopotentiating potential of MGN-3 may have been effective.
The patient is now taking MGN-3 1 g daily to prevent recurrence.
|
|
| No. 40 Breast cancer Facility/T Hospital
|
|
Patient's name/T. M AGE/48 years SEX/Female AREA/Shizuoka Prefecture
|
|
History of past diseases and treatments
In May 1996, the patient felt a lump in her left breast and visited a nearby obstetrics and
gynecology hospital for examination. She was diagnosed with breast cancer as a result of
histopathological study. She rejected the recommended immediate surgery. She looked for
hospitals that would perform breast conservation therapy but in vain. On October 5, she visited this
hospital. A close examination led to the judgment that a surgical procedure was best. However, the
patient was treated with Chinese medicine and a restricted diet upon her strong request. She was
given MGN-3 4 g daily to enhance immunopotency. Treatment continued and tumor markers were
checked monthly. Tumor marker points began to decrease in January 1997 and the tumor
disappeared on palpation in October. Histopathological study revealed no abnormal cells.
Changes caused by ingestion of MGN-3
About 2 months after start of treatment with MGN-3, she felt the lump in the breast begin softening
and the sense of incongruity fade.
Evaluation of MGN-3
Her cancer was so advanced that metastasis was naturally suspected but she was put on an
immunopotentiating therapy mainly consisting of MGN-3 in accordance with her strong request.
Tumor marker points began to decrease when her immunopotency seemed to have improved and
then the tumor disappeared after 1 year. We believe that activation of NK cells by MGN-3 led to
satisfactory results.
|
|
| No. 41 Chronic C type virus hepatitis Facility/K Hospital
|
|
Patient's name/Y. TK AGE/68 years SEX/Female AREA/Fukuoka Prefecture
|
|
History of past diseases and treatments
In April 1992, the patient developed severe fatigue and loss of strength in her extremities. An
examination revealed C type virus hepatitis. Blood transfusion performed 30 years before at an
obstetrics/gynecology operation was suspected as the cause but the true cause has not been
identified. Her fatigue improved as a result of rest for 1 month. In February 1996, she was operated
on for liver tumor. The operation itself was successful but she remained at the hospital for 3
months because of delayed recovery of physical strength. Her liver function was especially
damaged. Although the GOT, GPT and ?-GPT points remained at about 110, 140 and 140,
respectively, she left the hospital. She rested at home and waited for physical strength to recover
but she felt dizzy and lost 6 kg due to the lack of appetite. She began taking MGN-3 1 g after each
meal daily. After 6 months, her appetite and physical strength restored to the state before surgery
and the GOT, GPT and ?-GPT levels were within the normal limits.
Changes caused by ingestion of MGN-3
About 1 month after start of treatment with MGN-3, she began to feel a sense of exhaustion
disappear and she felt well upon awaking in the mornings. After 3 months, her appetite began to
improve and she stopped losing weight.
Evaluation of MGN-3
The immunopotentiating action and liver-protecting action of MGN-3 may have improved
symptoms of chronic hepatitis C.
|
|
| No. 42 Articular rheumatism Facility/N Hospital
|
|
Patient's name/T. K AGE/47 years SEX/Male AREA/Hyogo Prefecture
|
|
History of past diseases and treatments
In January 1997, the patient began feeling pain in the wrist and ankle. The pain in the left wrist and
ankle, in particular, was so strong as to disturb sleep. The pain was refractory to treatment with hot
pack and electrothermotherapy and even became stronger. A nearby physician suspected
rheumatism and he visited a national hospital for a complete medical checkup. He was diagnosed
with early-stage rheumatism. He did not respond to 2 months of medication only to lose physical
strength due to adverse effects of medication including insomnia and anorexia. At this time point,
he began taking MGN-3 2 g daily. Three months after, the pain in the joints of extremities began to
fade and after 6 months, disappeared. He is now taking MGN-3 1 g daily.
Changes caused by ingestion of MGN-3
Three days after start of treatment with MGN-3, the patient began to have good sleep and appetite.
He felt his body becoming warmer and the pain in the extremities began to feel milder.
Evaluation of MGN-3
The ability of MGN-3 to normalize immunity and mitigate adverse effects of medication helped
improve early-stage articular rheumatism.
|
|
| No. 43 Diabetes (NIDDM) Facility/K Hospital
|
|
Patient's name/Y. E AGE/58 years SEX/Male AREA/Fukuoka Prefecture
|
|
History of past diseases and treatments
In the middle of November, 1996, the patient presented with abnormal fatigue at a nearby hospital.
He had a blood sugar level of 300 mg/dl and a glycohemoglobin (HbA1c) level of 9.8 and was
diagnosed with diabetes. He also had complications of the disease. He was aware that he had been
eating too much sweet food since the summer but he attributed it to his being tired. For the
following month, he was put on a restricted diet and therapeutic exercise that consisted of 1 hour of
fast walking but these therapies had no effect. Because he was told that he had no choice but
undergo treatment with insulin, he visited K Hospital for other treatments. K Hospital
recommended taking MGN-3 3 g daily in addition to conventional treatment with a restricted diet
and exercise. One month after start of treatment with MGN-3, the blood sugar level decreased to
98 mg/dl and the glycohemoglobin level to 7.2. He is now taking MGN-3 1g daily.
Changes caused by ingestion of MGN-3
He began to feel fatigue being relieved 7 days after start of MGN-3 therapy. He no longer craved
sweet food and numbness of limbs decreased day-after-day.
Evaluation of MGN-3
Treatment with MGN-3 that has the ability to improve sugar metabolism led to a decrease in blood
sugar and an improvement in complications.
|
|
| No. 44 Chronic C type virus hepatitis,stomach cancer Facility/S Hospital
|
|
Patient's name/N. O AGE/67 years SEX/Female AREA/Osaka Prefecture
|
|
History of past diseases and treatments
The patient received blood transfusion in 1970 and contracted hepatitis. She had been living a
miserable life because of fatigue, malaise and chronic insomnia. She began to undergo treatment at
S Hospital where she was treated for a cold in October 1997 and was recommended to take MGN-3
3 g daily (1 g after each meal). Endoscopy performed after 6 days revealed 2 suspected cancer
lesions in the stomach. Reexamination for surgery performed after 2 weeks revealed the
disappearance of these 2 lesions. In late November, the GOT and GPT levels significantly
decreased to 55 and 46, respectively, compared to the levels before start of MGN-3 therapy. Her
insomnia was relieved. In 1998, her live function was normal and she recovered physical strength.
Changes caused by ingestion of MGN-3
About 10 days after start of MGN-3 therapy, she began to feel better and sleep soundly.
Evaluation of MGN-3
Treatment with the immunopotentiator MGN-3 helped eliminate hepatitis C virus and led to
eradication of early-stage stomach cancer lesions.
|
|
|
|
